BP005216: Human B7-H3/CD276 Protein with the C-hFc Tag
Source: The recombinant Human B7-H3/CD276 Protein, (amino acids Leu29-Pro245) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human B7-H3 protein with the C-hFc tag at 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Anti-B7-H3 Antibody protein with the C-hFc tag with the EC50 of 62.9 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005246: Human IL-1 Beta/IL-1F2 Protein with the C-His-Avi Tag
Source: The recombinant Human IL-1 Beta/IL-1F2 Protein, (amino acids Ala117-Ser269) fused with a His-Avi tag at the C-terminus, was produced in E.coli cells.
Activity: Immobilized recombinant Human IL-1 Beta protein with the C-His-Avi tag at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human IL-1R2 protein with the C-hFc tag with the EC50 of 0.12 ug/ml determined by ELISA (QC Test). The affinity constant of 0.88 nM as determined in SPR assay (Biacore T200).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004165: Human/Cynomolgus/Rhesus macaque ROR1 (30-305,Ig-like&Frizzled Domain) Protein with the C-His Tag
Source: The recombinant Human/Cynomolgus/Rhesus macaque ROR1 (30-305,Ig-like&Frizzled Domain) Protein, (amino acids Gln30-Asp305) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human/Cynomolgus/Rhesus macaque ROR1 (30-305,Ig-like&Frizzled Domain) protein with the C-His tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-ROR1 Antibody protein with the C-hFc tag with the EC50 of 3.0 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.